Home » Delcath Ousts CEO Amid Failed FDA Bid for Liver Cancer Treatment System
Delcath Ousts CEO Amid Failed FDA Bid for Liver Cancer Treatment System
Delcath lost a few more points after the company announced the termination of president & CEO Eamonn Hobbs, who will be replaced in the interim by two executives from within the company.
MassDevice
MassDevice
Upcoming Events
-
07May
-
14May
-
30May